Correlation Between Memphis Pharmaceuticals and Emaar Misr

Can any of the company-specific risk be diversified away by investing in both Memphis Pharmaceuticals and Emaar Misr at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Memphis Pharmaceuticals and Emaar Misr into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Memphis Pharmaceuticals and Emaar Misr for, you can compare the effects of market volatilities on Memphis Pharmaceuticals and Emaar Misr and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Memphis Pharmaceuticals with a short position of Emaar Misr. Check out your portfolio center. Please also check ongoing floating volatility patterns of Memphis Pharmaceuticals and Emaar Misr.

Diversification Opportunities for Memphis Pharmaceuticals and Emaar Misr

0.3

Correlation Coefficient

Memphis Pharmaceuticals  Emaar Misr

Weak diversification

The 3 months correlation between Memphis and Emaar is 0.3. Overlapping area represents the amount of risk that can be diversified away by holding Memphis Pharmaceuticals and Emaar Misr for in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emaar Misr for and Memphis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Memphis Pharmaceuticals are associated (or correlated) with Emaar Misr. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emaar Misr for has no effect on the direction of Memphis Pharmaceuticals i.e., Memphis Pharmaceuticals and Emaar Misr go up and down completely randomly.

Pair Corralation between Memphis Pharmaceuticals and Emaar Misr

Assuming the 90 days trading horizon Memphis Pharmaceuticals is expected to generate 2.86 times more return on investment than Emaar Misr. However, Memphis Pharmaceuticals is 2.86 times more volatile than Emaar Misr for. It trades about 0.13 of its potential returns per unit of risk. Emaar Misr for is currently generating about -0.05 per unit of risk. If you would invest  3,632  in Memphis Pharmaceuticals on September 25, 2024 and sell it today you would earn a total of  1,593  from holding Memphis Pharmaceuticals or generate 43.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	98.08%
Values	Daily Returns

Memphis Pharmaceuticals  vs.  Emaar Misr for

Memphis Pharmaceuticals

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Memphis Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Memphis Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Emaar Misr for

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Emaar Misr for has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's technical and fundamental indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Pair Trading with Memphis Pharmaceuticals and Emaar Misr

The main advantage of trading using opposite Memphis Pharmaceuticals and Emaar Misr positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Memphis Pharmaceuticals position performs unexpectedly, Emaar Misr can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emaar Misr will offset losses from the drop in Emaar Misr's long position.

The idea behind Memphis Pharmaceuticals and Emaar Misr for pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.